Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial

Wanpu Yan, Yi‐Long Wu, Yan‐Hui Liu et al.|Journal of Thoracic Oncology|2022

Cited by 34